BKM Wealth Management LLC Increases Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

BKM Wealth Management LLC boosted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 8.3% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 5,927 shares of the healthcare conglomerate’s stock after purchasing an additional 454 shares during the quarter. UnitedHealth Group makes up approximately 1.2% of BKM Wealth Management LLC’s investment portfolio, making the stock its 19th largest holding. BKM Wealth Management LLC’s holdings in UnitedHealth Group were worth $2,998,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently bought and sold shares of UNH. AlphaMark Advisors LLC purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at $30,000. RPg Family Wealth Advisory LLC acquired a new stake in UnitedHealth Group in the 3rd quarter valued at $37,000. DecisionPoint Financial LLC raised its position in shares of UnitedHealth Group by 155.0% during the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock worth $52,000 after purchasing an additional 62 shares during the last quarter. Highline Wealth Partners LLC acquired a new stake in shares of UnitedHealth Group in the third quarter worth approximately $55,000. Finally, Legacy Investment Solutions LLC acquired a new stake in shares of UnitedHealth Group in the third quarter valued at about $57,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Activity

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction dated Friday, January 17th. The shares were bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Down 1.4 %

Shares of UNH opened at $523.48 on Tuesday. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The business’s 50 day simple moving average is $523.11 and its 200-day simple moving average is $563.00. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The company has a market capitalization of $481.75 billion, a P/E ratio of 33.77, a PEG ratio of 1.45 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm’s quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter in the prior year, the business posted $5.83 EPS. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

Wall Street Analyst Weigh In

UNH has been the topic of a number of research analyst reports. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price on the stock in a report on Friday, January 10th. Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Piper Sandler dropped their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. Finally, Deutsche Bank Aktiengesellschaft increased their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. One equities research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.